bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Here’s Why

bioMerieux (OTCMKTS:BMXMF) gapped up prior to trading on Thursday. The stock had previously closed at $95.00, but opened at $99.55. bioMerieux shares last traded at $99.55, with a volume of 32 shares changing hands.

Analysts Set New Price Targets

A number of research firms have commented on BMXMF. Morgan Stanley restated an “underweight” rating on shares of bioMerieux in a research note on Friday, September 11th. Zacks Research raised bioMerieux from a “strong sell” rating to a “hold” rating in a research note on Monday, September 28th. Five equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Reduce”.

bioMerieux Stock Performance

The company’s 50-day moving average price is $87.26 and its 200-day moving average price is $86.03.

bioMerieux Company Profile

bioMérieux is a France-based company specializing in in vitro diagnostics. It develops and manufactures diagnostic systems, reagents, software and services used to detect disease, identify infectious organisms and support treatment decisions. Its offerings serve hospitals, clinical laboratories and other healthcare providers, with a particular focus on infectious diseases, antimicrobial resistance and syndromic testing.

The company also provides industrial microbiology solutions for applications such as food safety, pharmaceutical manufacturing and quality control.